Cargando…

Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies

Adaptation to import iron for proliferation makes cancer cells potentially sensitive to iron toxicity. Iron loading impairs multiple myeloma (MM) cell proliferation and increases the efficacy of the proteasome inhibitor bortezomib. Here, we defined the mechanisms of iron toxicity in MM.1S, U266, H92...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bordini, Jessica, Morisi, Federica, Cerruti, Fulvia, Cascio, Paolo, Camaschella, Clara, Ghia, Paolo, Campanella, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226326/ https://www.ncbi.nlm.nih.gov/pubmed/32295216 http://dx.doi.org/10.3390/cancers12040970

Ejemplares similares

Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
por: Cerruti, Fulvia, et al.
Publicado: (2017)

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Bordini, Jessica, et al.
Publicado: (2023)

Iron & disease
por: Camaschella, Clara
Publicado: (2018)

Regulating Proteasome Activity
por: Cascio, Paolo, et al.
Publicado: (2022)

Bmp6 Expression in Murine Liver Non Parenchymal Cells: A Mechanism to Control their High Iron Exporter Activity and Protect Hepatocytes from Iron Overload?
por: Rausa, Marco, et al.
Publicado: (2015)

PA28αβ: The Enigmatic Magic Ring of the Proteasome?
por: Cascio, Paolo
Publicado: (2014)

PA28γ: New Insights on an Ancient Proteasome Activator
por: Cascio, Paolo
Publicado: (2021)

Iron metabolism and iron disorders revisited in the hepcidin era
por: Camaschella, Clara, et al.
Publicado: (2020)

A potential pathogenetic role of iron in Alzheimer's disease
por: Silvestri, Laura, et al.
Publicado: (2008)

P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS
por: Pseftogkas, Athanasios, et al.
Publicado: (2023)

The extrahepatic role of TFR2 in iron homeostasis
por: Silvestri, Laura, et al.
Publicado: (2014)

A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells
por: Milan, Enrico, et al.
Publicado: (2015)

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2021)

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
por: Peters, N. O., et al.
Publicado: (2017)

Are lipid nanoparticles really superior? A holistic proof of concept study
por: Wiemann, Sabrina, et al.
Publicado: (2021)

Proteasome Inhibitors for the Treatment of Multiple Myeloma
por: Ito, Shigeki
Publicado: (2020)

Concept and application of circulating proteasomes
por: Choi, Won Hoon, et al.
Publicado: (2021)

Identification of TMPRSS6 cleavage sites of hemojuvelin
por: Rausa, Marco, et al.
Publicado: (2015)

Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities
por: Fuchs, Flavio Danni, et al.
Publicado: (2012)

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target
por: Sbrana, Francesca Vittoria, et al.
Publicado: (2023)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

MSC Senescence-Related Genes Are Associated with Myeloma Prognosis and Lipid Metabolism-Mediated Resistance to Proteasome Inhibitors
por: Cao, Yang-Jia, et al.
Publicado: (2022)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
por: Acosta-Alvear, Diego, et al.
Publicado: (2015)

The Versatile Transceiver Proof of Concept
por: Troska, J, et al.
Publicado: (2009)

Therapeutic Liquid Eutectic Solvents in Lipid Nanoparticles as Drug Vehicles—A Proof of Concept
por: Gonçalves, Joana, et al.
Publicado: (2023)

Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma
por: Barbato, Alessandro, et al.
Publicado: (2023)

Mandibular Flexure and Its Significance: An In Vivo Cone Beam-Computed Tomography Proof-of-Concept Study
por: Londono, Jimmy, et al.
Publicado: (2023)

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
por: Tundo, Grazia Raffaella, et al.
Publicado: (2022)

Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3
por: Boulpicante, Mathilde, et al.
Publicado: (2020)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells
por: Ge, Feng, et al.
Publicado: (2010)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
por: Merin, Noah M., et al.
Publicado: (2014)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

Proteasome inhibition: the dawn of novel therapies in multiple myeloma
por: Engelhardt, Monika, et al.
Publicado: (2022)

Comprehensive Insight into Colorectal Cancer Metabolites and Lipids for Human Serum: A Proof-of-Concept Study
por: Bhatt, Kinjal, et al.
Publicado: (2023)

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
por: Gu, Yanyan, et al.
Publicado: (2020)

The LHCb Grid simulation: Proof of concept
por: Hushchyn, M, et al.
Publicado: (2017)

DNA watermarks: A proof of concept
por: Heider, Dominik, et al.
Publicado: (2008)

Groupness in Preverbal Infants: Proof of Concept
por: Bradley, Benjamin Sylvester, et al.
Publicado: (2017)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_18c5m6502pi6m4omf7hjma4a5g